Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Protagonist Therapeutics

152.82
-1.5000-0.97%
Volume:86.15K
Turnover:13.14M
Market Cap:9.89B
PE:148.37
High:158.08
Open:154.32
Low:150.00
Close:154.32
52wk High:160.81
52wk Low:54.50
Shares:64.71M
Float Shares:63.17M
Volume Ratio:0.45
T/O Rate:0.14%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.03
EPS(LYR):-2.0500
ROE:10.98%
ROA:4.55%
PB:11.75
PE(LYR):-74.55

Loading ...

OverviewCompanyNewsFilings

Protagonist Therapeutics Q4 revenue drops on lower milestone payments

Reuters
·
Feb 26

Protagonist Therapeutics Inc: Nda for Rusfertide Submitted to US FDA With Potential Approval & Launch This Year

THOMSON REUTERS
·
Feb 26

Protagonist Therapeutics: to Opt-Out of 50:50 Profit Sharing Arrangement for Rusfertide With Takeda During a 90-Day Window Expected to Open in Q2

THOMSON REUTERS
·
Feb 26

Protagonist Therapeutics posts FY 2025 license and collaboration revenue of USD 46.0 million down 89.4%

Reuters
·
Feb 26

Protagonist Therapeutics CEO Dinesh V. Patel to Speak at Multiple Investment Bank Conferences in March 2026

Reuters
·
Feb 24

Analyst Rate

Buy
Buy
100.00%
Hold
0.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 05, 2026 Post-Mkt
Financial Report Announcement
May 05, 2026 Post-Mkt
Financial Report Announcement
Feb 25, 2026 Post-Mkt
Financial Report Announcement
Nov 06, 2025 Post-Mkt
Financial Report Announcement
Aug 06, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

149.83
Current
7.21
Sector Average
97.55%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
149.83
Maximum
125.62
+1 STD
49.65
Minimum
-77.73
-1 STD
-35.23
Average
7.21

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.